TNFRSF9 and colorectal carcinoma: In the present study, we assessed the expression of the CD137 or CD107a in NK cells and CD8+T cells from cetuximab‐treated patients with CRC, and elevated expression of CD137 and CD107a were observed in NK cells after effective cetuximab treatment.